Literature DB >> 23611997

JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population.

Ke Hu1, Shengping Hou, Fuzhen Li, Qin Xiang, Aize Kijlstra, Peizeng Yang.   

Abstract

PURPOSE: Janus kinase 1 (JAK1), JAK2, and signal transducer and activator of transcription 3 (STAT3) play an important role in Th1 and Th17 differentiation and gene polymorphisms of these factors have been demonstrated to be associated with certain autoimmune diseases. The present study was performed to assess the association between JAK1, JAK2, and STAT3 polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population.
METHODS: A case-control study was performed in 737 Chinese VKH syndrome patients and 809 healthy controls from a Han Chinese population. The genotypes of three single-nucleotide polymorphisms (SNPs) (rs310230, rs310236, rs310241) in JAK1 were performed using an SNP genotyping system. Three SNPs (rs10758669, rs7857730, rs10119004) in JAK2 and four SNPs (rs6503695, rs744166, rs2293152, and rs12948909) in STAT3 were analyzed using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Hardy-Weinberg equilibrium (HWE) was tested using the χ(2) test. Genotype frequencies were estimated through direct counting. Allele and genotype frequencies were compared between patients and controls using the χ(2) test.
RESULTS: There was no deviation from the HWE in all controls tested. Three SNPs, including rs310230, rs310236, and rs310241, in JAK1 were significantly associated with VKH syndrome (Pc = 0.008, 0.005, 0.001, respectively). None of the tested SNPs of JAK2 and STAT3 was associated with VKH syndrome. Stratification analysis according to headache, dysacusis, alopecia, poliosis, and vitiligo for VKH syndrome did not reveal an association.
CONCLUSIONS: These results suggest that JAK1 genetic polymorphisms, but not JAK2 and STAT3, are associated with the susceptibility to VKH syndrome.

Entities:  

Keywords:  JAK1; JAK2; STAT3; VKH; polymorphisms

Mesh:

Substances:

Year:  2013        PMID: 23611997     DOI: 10.1167/iovs.13-11615

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population.

Authors:  S Y Kim; M S Hur; B G Choi; M J Kim; Y W Lee; Y B Choe; K J Ahn
Journal:  Clin Exp Immunol       Date:  2016-11-24       Impact factor: 4.330

2.  Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus.

Authors:  Valéria Bumiller-Bini Hoch; Ana Flávia Kohler; Danillo G Augusto; Sara Cristina Lobo-Alves; Danielle Malheiros; Gabriel Adelman Cipolla; Angelica Beate Winter Boldt; Karin Braun-Prado; Michael Wittig; Andre Franke; Claudia Pföhler; Margitta Worm; Nina van Beek; Matthias Goebeler; Miklós Sárdy; Saleh Ibrahim; Hauke Busch; Enno Schmidt; Jennifer Elisabeth Hundt; Patrícia Savio de Araujo-Souza; Maria Luiza Petzl-Erler
Journal:  Viruses       Date:  2022-04-23       Impact factor: 5.818

3.  Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo.

Authors:  Rehab M Samaka; Mohammed A Basha; Dina Menesy
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-06-28

Review 4.  Influence of molecular genetics in Vogt-Koyanagi-Harada disease.

Authors:  Joanne Yw Ng; Fiona Oj Luk; Timothy Yy Lai; Chi-Pui Pang
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-07-22

5.  Lack of Association between Genetic Polymorphisms of JAK-STAT Signaling Pathway Genes and Acute Anterior Uveitis in Han Chinese.

Authors:  Ling Cheng; Hongsong Yu; Yan Jiang; Juan He; Sisi Pu; Xin Li; Li Zhang
Journal:  Biomed Res Int       Date:  2016-11-14       Impact factor: 3.411

6.  PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.

Authors:  Lei Xu; Tingting Zhao; Gangxiang Yuan; Shengping Hou; Wenxin Zeng; Feilan Chen
Journal:  Mol Vis       Date:  2019-12-02       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.